- Report
- November 2023
- 250 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- December 2024
- 88 Pages
Egypt
From €3327EUR$3,500USD£2,795GBP
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 88 Pages
Malaysia
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2024
- 111 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- January 2024
- 83 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- January 2024
- 77 Pages
Africa, Middle East
From €3280EUR$3,450USD£2,755GBP
- Report
- January 2024
- 87 Pages
Asia Pacific
From €3280EUR$3,450USD£2,755GBP
- Report
- October 2023
- 133 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- October 2023
- 123 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- August 2023
- 165 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- February 2024
- 197 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- January 2024
- 147 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- September 2022
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP

The Transcatheter Aortic Valve Replacement (TAVR) market is a segment of the Cardiovascular Devices industry. It is a minimally invasive procedure used to replace a diseased aortic valve with a prosthetic valve. The procedure is typically used in patients who are at high risk for open-heart surgery. The TAVR market has seen rapid growth in recent years due to its advantages over traditional open-heart surgery, such as shorter recovery times and lower risk of complications.
The TAVR market is highly competitive, with a number of companies offering products and services. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. These companies offer a range of products, including prosthetic valves, delivery systems, and accessories. Additionally, many of these companies have developed partnerships with healthcare providers to expand their reach and increase their market share. Show Less Read more